KS Albain

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Agnieszka Woźniak, John J. Crowley, S P Balcerzak et al. · Journal of Clinical Oncology · 1998 · 566 citations

Abstract GS1-02: NSABP B-47 (NRG oncology): Phase III randomized trial comparing adjuvant chemotherapy with adriamycin (A) and cyclophosphamide (C) → weekly paclitaxel (WP), or docetaxel (T) and C with or without a year of trastuzumab (H) in women with node-positive or high-risk node-negative invasive breast cancer (IBC) expressing HER2 staining intensity of IHC 1+ or 2+ with negative FISH (HER2-Low IBC)

L. Fehrenbacher, RS Cecchini, CE Geyer et al. · Cancer Research · 2018 · 50 citations

Breast Oncology, Cancer Management, Adjuvant Chemotherapy +17

Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

SM Tolaney, WT Barry, CT Dang et al. · Cancer Research · 2013 · 36 citations

Dfs Events, Breast Oncology, Overall Survival +12

S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.

KS Albain, Cheryl Czerlanis, Andrei Zlobin et al. · Cancer Research · 2011 · 18 citations

Breast Oncology, Chemoprevention Strategy, Pharmacotherapy +17

ABREAST: A new global registry of adjuvant strategies in patients with early stage breast cancer

Jaime de Salazar, Tadeusz Pieńkowski, Matti Aapro et al. · Journal of Clinical Oncology · 2005 · 17 citations

Surgical Oncology, Breast Oncology, Cancer Management +21